ABL Attended ImVacs Conference in Boston, August 13-15

The 8th Annual Immunotherapeutics and Vaccine Summit (ImVacs) is taking place at the Hilton Boston Back Bay Hotel in Boston on August 13-15. ABL representatives will be on site to discuss how ABL applies our research and manufacturing capabilities to the development of immunotherapeutics and vaccines. The focus of the 2013 ImVacs conference is novel vaccines.

This year’s ImVacs conference is co-located with the Immunotherapies Congress whose meeting will be focused on immunotherapies and vaccines targeting cancer.